Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 and Phase 2 Clinical Trials of Cancer Chemoprevention Agents
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Specialized Center for Oral Inflammation and Resolution
Uw/Fhcrc Training in Hemoglobinpathies, Genomics and Proteomics
NMR Studies of HIV-1 Proteins
Metabolic Regulation of Lipoprotein Lipase in Adipocyte
Prevention Research Training:Urban Children's Ment Hlth
Recently added grants:
Molecular Mechanisms Regulating Immunoglobulin Diversification
Development of Single Molecule Chromatin Interaction Assays (smChIA) in Single Nuclei
Structural mechanisms of chromatin assembly
A marker-free technology for mapping the epigenome of cell types in mammalian tissues
Precision Medicine by Harmonizing Real World Evidence and RCT Data
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35153-9-0-1
Application #
7579653
Study Section
Project Start
2003-09-30
Project End
2008-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemoprevention Agents
/ University of Wisconsin Madison
$1,614,000
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
Bailey, Howard /
$1,058,141
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemoprevention Agents
/
Comments
Be the first to comment on this grant